Waratah Vaccine Trial Alliance

Project summary A multidisciplinary collaboration of leading and emerging clinical vaccine trial researchers, consumers and other stakeholders. What is the issue for NSW? The COVID-19 pandemic has highlighted an urgent need to have the capability and infrastructure in NSW to attract and conduct vaccine trials for the benefit of the NSW community, including potential COVID-19 vaccines. The Alliance will establish NSW as a premier site in Australia for vaccine trial research and support COVID-19 related vaccine clinical trials and beyond. The Alliance will also work towards scaling up clinical vaccine trials by engaging: all NSW LHDs/Sydney Children's Hospital Network private health system community health services General Practice and aged care facilities including rural, remote and regional areas. What does the research aim to do and how? The Waratah Vaccine Alliance will be a centralised 'one-stop-shop' for industry and investigators interested in conducting vaccine trials in NSW. The Alliance will ensure: Collaboration of all NSW vaccine stakeholders in a coordinated approach to vaccine development Centralised coordination node for industry and investigators to conduct a vaccine trial in NSW. Increase access to clinical vaccine trials for the population of NSW Improved trial conduct and population health outcomes Provide a forum for consumer involvement and Produce the next generation of clinical vaccine trialists.